Tim Juergens
Angel Investor
Barcelona, Spain
Tim Juergens is a Co-Founder & General Manager of SeedLink SL.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Tim Juergens invests in
Stages Tim Juergens invests in
Countries Tim Juergens invests in
Round sizes
Round size
- Pre-Seed
- $269k–$1.2M
Investment Focus
Industry
- Health Care 4 (80%)
- Personal Health 2 (40%)
- Medical 1 (20%)
- mHealth 1 (20%)
- Diabetes 1 (20%)
Stage
- Pre-Seed 3 (60%)
- Seed 2 (40%)
Country
- Germany 3 (60%)
- Switzerland 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OneTwenty
|
OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes. | Seed / Mar 01, 2025 | |
Hale
|
Precision care for genito-pelvic pain. | $269.3K / Pre-Seed / May 12, 2024 | |
|
OneTwenty
|
OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes. | Pre-Seed / Jan 19, 2024 | |
Skinuvita
|
Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home. | $1.2M / Pre-Seed / Apr 01, 2022 | |
XO Life
|
XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications. | $2.3M / Seed / Feb 16, 2022 |
Co-Investors
DvH Ventures
3 deals together
Tiny Supercomputer Investment Company
2 deals together
1921
1 deal together
Aescuvest
1 deal together
GCP-Service Invest
1 deal together
Growing Well Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Tim Juergens invest in?
Tim Juergens invests primarily in Health Care, Personal Health and Medical startups, most often at Pre-Seed and Seed stage. Most of the 5 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Tim Juergens's check size?
Tim Juergens typically joins rounds of $269k–$1.2M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tim Juergens participates in.
When did Tim Juergens last invest?
The most recent investment recorded for Tim Juergens closed in May 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
